mBio. 2024 Apr 10;15(4):e0268623. doi: 10.1128/mbio.02686-23. Epub 2024 Mar 12.
3
Alternative substitutions of N332 in HIV-1 gp120 differentially affect envelope glycoprotein function and viral sensitivity to broadly neutralizing antibodies targeting the V3-glycan.